Comerica Bank’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Comerica Bank’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-599	Closed	-$8K	–	2318
2019 Q4	$8K	Hold	599	–	–	﹤0.01%	2277
2019 Q3	$7K	Hold	599	–	–	﹤0.01%	2271
2019 Q2	$13K	Hold	599	–	–	﹤0.01%	2288
2019 Q1	$37K	Hold	599	–	–	﹤0.01%	2257
2018 Q4	$32K	Hold	599	–	–	﹤0.01%	2250
2018 Q3	$42K	Hold	599	–	–	﹤0.01%	2257
2018 Q2	$70K	Buy	+599	New	+$60.1K	﹤0.01%	2250
2017 Q1	–	Sell	-258	Closed	-$16K	–	2222
2016 Q4	$16K	Hold	258	–	–	﹤0.01%	2178
2016 Q3	$19K	Hold	258	–	–	﹤0.01%	2098
2016 Q2	$20K	Sell	258 -500	-66%	-$95.3K	﹤0.01%	2084
2016 Q1	$200K	Buy	+758	New	+$242K	﹤0.01%	2003

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's SRRA Position: Q1 2020 in Review

Comerica Bank sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 599 shares — an estimated $8K sold.

Comerica Bank first reported a position in SRRA in Q1 2016 and held it in 11 quarters. The position peaked at $200K in Q1 2016. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

Comerica Bank reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Comerica Bank sold 599 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $8K.
Comerica Bank first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 11 quarters.
Comerica Bank's Sierra Oncology, Inc. Common Stock position peaked at $200K in Q1 2016.
22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Comerica Bank's 13F filing for Q1 2020, filed 1 May 2020.